Home > Compound List > Product Information
Famciclovir_Molecular_structure_CAS_104227-87-4)
Click picture or here to close

Famciclovir

Catalog No. Bio-0039 Name InterBioScreen
CAS Number 104227-87-4 Website http://www.ibscreen.com
M. F. C14H19N5O4 Telephone +7 49652 40091
M. W. 321.33176 Fax
Purity Email screen@ibscreen.chg.ru
Storage Chembase ID: 309

SYNONYMS

IUPAC name
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate
IUPAC Traditional name
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate
Synonyms
Famvir

DATABASE IDS

CAS Number 104227-87-4

PROPERTIES

Application(s) Antiviral drug
Application(s) Used for the treatment of various herpes virus infections, most commonly for herpes zoster (shingles).
Mechanism of Action Guanine analogue
Mechanism of Action Prodrug of penciclovir with improved oral bioavailability
Mechanism of Action Undergoes rapid biotransformation to penciclovir
Mechanism of Action In cells infected with HSV-1, HSV-2 or VZV, viral thymidine kinase phosphorylates penciclovir to a monophosphate form
Mechanism of Action that, in turn, is converted to penciclovir triphosphate by cellular (human) kinases
Mechanism of Action Penciclovir triphosphate selectively inhibits viral DNA polymerase by competing with deoxyguanosine triphosphate
Mechanism of Action Consequently, herpes viral DNA synthesis and replication are selectively inhibited.

DETAILS

REFERENCES

  • Eur. Pat., 1986, Beecham, 182 024; CA, 105, 133669, (synth, pmr, pharmacol)
  • Vere Hodge, R.A. et al., Antimicrob. Agents Chemother., 1989, 33, 1765, (synth, pharmacokinet)
  • Genn, G.R. et al., J. Med. Chem., 1989, 32, 1738, (synth)
  • Winton, C.F. et al., Anal. Proc. (London), 1990, 27, 181, (hplc)
  • Harnden, M.R. et al., Nucleosides Nucleotides, 1990, 9, 499, (cryst struct)
  • Vere Hodge, R.A., Antiviral Chem. Chemother., 1993, 4, 67, (rev)
  • Sutton, D. et al., Antiviral Res., 1993, 4, 37, (rev)
  • Vere Hodge, R.A. et al., Chirality, 1993, 5, 577, (metab)
  • Filer, C.W. et al., Xenobiotica, 1994, 24, 357, (metab, pharmacokinet, human)
  • Cirelli, R. et al., Antiviral Res., 1996, 29, 141, (rev, pharmacol)
  • Brand, B. et al., Tetrahedron, 1999, 55, 5239-5252, (synth, pmr, cmr)
  • Freer, R. et al., Tetrahedron, 2000, 56, 4589-4595, (synth, pmr, cmr)